Stockreport

Earnings Update: Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Reported And Analysts Are Trimming Their Forecasts [Yahoo! Finance]

Kymera Therapeutics, Inc.  (KYMR) 
PDF Revenues beat expectations, with US$79m in revenue being 13% above estimates. The company still lost US$2.52 per share, tracking roughly in line with expectations. The a [Read more]